Development of a One-Step RT-LAMP-CRISPR/Cas12b Assay for Rapid On-Site Detection of Dabie Bandavirus
ACS Omega · 03.11.2026 · 11 (43) · 66547-66556
DOI: 10.1021/acsomega.6c05919 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 22.10.2026. Verfasst von Jinlei Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Jiangsu Provincial Bureau of Disease Control and Prevention.
Abstract (Originalsprache)
Severe fever with thrombocytopenia syndrome (SFTS), caused by Dabie bandavirus (DBV), has rapidly spread to multiple countries worldwide since its discovery in 2009, posing a serious threat to global public health security. SFTS is a tick-borne disease, and people living in mountainous and hilly areas are at increased risk of infection, which highlights the urgent need for rapid, accurate, and field-applicable diagnostic strategies for DBV. In this study, LAMP primers and CRISPR sgRNA were designed based on the conserved region of the DBV L segment. A one-pot, one-step molecular assay integrating reverse transcription loop-mediated isothermal amplification (RT-LAMP) with CRISPR/Cas12b technology was established after systematic optimization of key parameters. The assay operates under isothermal conditions at 60 °C, delivering results within 40 min. Analytical evaluation demonstrated a limit of detection of 25.6 RNA copies per reaction. No cross-reactivity was observed with Hantaan virus, Seoul virus, Chikungunya virus, Japanese encephalitis virus, Dengue virus, and Zika virus. Clinical validation using 42 specimens showed complete concordance with gold-standard qRT-PCR, achieving 100% sensitivity (30/30) and 100% specificity (12/12). For point-of-care application, fluorescence visualization was incorporated into the CRISPR/Cas-based detection workflow, enabling straightforward result interpretation. This integrated RT-LAMP-CRISPR/Cas12b platform provides rapid and specific detection of DBV through a simplified workflow that does not require complex instrumentation, supporting its potential application in resource-limited environments.
Autor:innen und Institutionen
- NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
ORCID-Profile: Jinlei Guo
Förderung
- National Key Research and Development Program of China
- Jiangsu Provincial Bureau of Disease Control and Prevention
Zitieren
APA
Guo, J., Wu, T., Qiao, Q., Zhu, X., Zhao, K., Cui, L., Huo, X., & Ge, Y. (2026). Development of a One-Step RT-LAMP-CRISPR/Cas12b Assay for Rapid On-Site Detection of Dabie Bandavirus. ACS Omega, 11(43), 66547-66556. https://doi.org/10.1021/acsomega.6c05919
Vancouver
Guo J, Wu T, Qiao Q, Zhu X, Zhao K, Cui L, et al. Development of a One-Step RT-LAMP-CRISPR/Cas12b Assay for Rapid On-Site Detection of Dabie Bandavirus. ACS Omega. 2026;11(43):66547-66556. doi:10.1021/acsomega.6c05919
BibTeX
@article{Guo2026,
author = {Guo, Jinlei and Wu, Tao and Qiao, Qiao and Zhu, Xiaojuan and Zhao, Kangchen and Cui, Lunbiao and Huo, Xiang and Ge, Yiyue},
title = {Development of a One-Step RT-LAMP-CRISPR/Cas12b Assay for Rapid On-Site Detection of Dabie Bandavirus},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {43},
pages = {66547--66556},
doi = {10.1021/acsomega.6c05919}
}
EUVIMED